lundi , novembre 11 2019

Evadeô Pro

Middle East

P.O. Box 45526 Abu Dhabi, UAE
Hamdane Street
AlGhaith Tower
Phone: +971 (0)2.508.9095
Mobile: +971 (0)55.660.3238
E-mail: contact@evadeopro.com

Evadeô Pro


6 bis rue Denis Papin
94450 Limeil Brevannes – France
Phone: + 33 (0)1.45.10.18.04
Mobile: + 33 (0)7.66.12.97.17
E-mail: contact@evadeopro.fr

Your Health, Our motto !     The specialist in medical tourism and medical evacuation toward France

caroussel-evadeo-pro-885x350
7
4
3
2
5
Home / News / Amyotrophic Lateral Sclerosis (ALS), in other words Charcot’s Disease

Amyotrophic Lateral Sclerosis (ALS), in other words Charcot’s Disease

It is a rare disease and affects about 8,000 people in France (1 in 1,000 people), and nearly 120,000 people worldwide, or about 328 new cases every day, and represents 1/3 of neuromuscular disorders. ALS usually starts around the age of 55. It affects both men and women equally.

A neurodegenerative disease, rare, incurable, rapidly progressive, it is the cause of progressive motor disability leading to paralysis. It can begin at any level of the body, then spread in a few months or years to all four limbs and the head, and can cause death on average 2 to 5 years after the first symptoms.

Gradually, the person loses the ability to mobilize their voluntary muscles.
She loses the use of her speech, can no longer move, swallow and, finally, breathe.

However, ALS does not affect any of the five senses (vision, taste, smell, touch, hearing). It also generally does not affect the muscles of the eye, heart, bladder, intestine and sexual organs.

Amyotrophic lateral sclerosis is caused by the loss of motor neurons (or motor neurons) and whose mechanisms responsible for ALS, including the degeneration of motor neurons, remain unknown to this day.

ALS management is multidisciplinary: neurologists, reeducators, pulmonologists, gastroenterologists, speech therapists, physiotherapists, dieticians, nurses, palliative care units, attending physicians and all participate in the management.

1,350 patients are monitored at the Pitié-Salpêtrière site in Paris, including approximately 430 new cases treated each year among the 1,000 new cases recorded each year in France.

EVADEO PRO in partnership with many specialists is able to assist you in the diagnosis and treatment of this pathology. We assist you in your care journey as part of a complete health check-up, during a medical evacuation or during a medical stay for the treatment of this disease.
And because Evadeô Pro appears as the leader in medical tourism in France, we also offer you to enhance your stay by selecting among our services at a preferential price, those that correspond to your desires or your needs…

Ask to be called back, or contact us by phone or email to tell us your needs; our team will do the rest!

Evadêo Pro – Leader in healthcare stays and medical tourism in France.

Vérifiez également

Infantile congenital malformations

Birth defects (at birth) are not uncommon, accounting for an estimated 1 in 33 births ...